Over 37 million Americans are currently managing diabetes, with a growing number being diagnosed at a younger age—particularly with type 2 diabetes, NaijNaira can report.
According to Knowridge, researchers have unveiled a promising approach called Re-cellularization via Electroporation Therapy, or ReCET, aimed at reducing the need for daily insulin injections in type 2 diabetes patients.
ReCET uses brief electric pulses to modify the inner lining of the small intestine. The procedure is done using an endoscope, a slim camera-equipped tube inserted through the mouth, allowing doctors to precisely reach the small intestine.
A pilot study involved 14 individuals with type 2 diabetes who received the ReCET procedure. Following treatment, they followed a controlled diet for two weeks, then began semaglutide therapy—a drug already known for its blood sugar-lowering benefits.
“Most participants were able to stop insulin injections entirely while maintaining stable glucose levels,” the researchers stated.
Scientists believe ReCET may help the body respond to insulin more effectively, which could reduce dependency on external insulin.
While initial results are encouraging, experts stress that larger studies are necessary to confirm long-term safety and effectiveness.
Alongside medical treatments, maintaining a balanced diet, regular physical activity, and avoiding harmful habits remain essential for managing type 2 diabetes.
Article updated 2 months ago. Content is written and modified by multiple authors.
